From climate and public lands to shifting political allegiances, the region faces critical choices at the ballot box.

Gift 5 articles to anyone you choose each month when you subscribe. Times are good at Eli Lilly. Wall Street’s insatiable appetite for weight-loss drug stocks looks set to turn the company into ...

Eli Lilly's GLP-1 weight-loss drugs Mounjaro and Zepbound have been removed from the Food and Drug Administration's (FDA) shortage list.Yahoo Finance Senior Health Reporter Anjalee Khemlani ...

That seemed to be the case for former Alabama quarterback Eli Holstein, who entered the transfer portal after last season after one year in Tuscaloosa. Holstein announced his transfer from Alabama ...

Eli Lilly anticipates regulatory approval for its weight-loss drug Zepbound in Japan by mid-2025, boosting its global portfolio If Medicare were to start covering popular weight loss drugs such as ...

Eli Lilly and Company (NYSE: LLY) today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. This unique facility ...

Eli Lilly has ben able to increase its manufacturing capacity to meet demand for its GLP-1 drugs. The company hopes this will reduce competition from drug compounding businesses. The stock looks ...

Eli Lilly exhibits robust revenue growth, with Q2 revenue surging by 36%, driven by new products contributing nearly $3.5 billion compared to the same period last year (David Ricks, Chair and CEO).

Eli Lilly has become a household name thanks to breakthrough diabetes and obesity care medicines. The stock has trounced the broader market over the past year, and shares have become a bit pricey ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Manning, the legendary Giants quarterback who's also part of the football success of the Mannings, recently poked some fun at Arch's starting debut for Texas and how it stacks up against the ...